SCHEMBL6173699

SCHEMBL6173699

CC(c1cc(N(C)C)nc2ccccc12)C1NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
ACP1 P24666 1/20 0.41
CXCR3 P49682 2/20 0.37
MC4R P32245 1/20 0.37
MC1R Q01726 1/20 0.37
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
IGF1R P08069 2/20 0.35
LIPE Q05469 1/20 0.34
MGLL Q99685 1/20 0.34
CASR P41180 2/20 0.33
MCHR1 Q99705 2/20 0.33
OPRL1 P41146 1/20 0.33
GPR139 Q6DWJ6 2/20 0.33
PDE2A O00408 1/20 0.33
ADAM17 P78536 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177161 0.88 LMNA (0.45) LMNAACP1CXCR3MC4RMC1R
SCHEMBL6173087 0.85 IGF1R (0.41) LMNAIGF1R
SCHEMBL6175470 0.79 ACP1 (0.41) ACP1CXCR3MC4RMC1RPOLB
SCHEMBL6175890 0.77 LMNA (0.39) LMNAACP1CXCR3POLBL3MBTL1
SCHEMBL6172286 0.76 LMNA (0.41) LMNACXCR3POLBL3MBTL1CASR
SCHEMBL6175754 0.74 LMNA (0.39) LMNAIGF1RPDE2A
SCHEMBL6175824 0.74 LMNA (0.39) LMNAPOLBIGF1RPDE2AADAM17
SCHEMBL6171605 0.73 LMNA (0.39) LMNAIGF1RPDE2A
SCHEMBL6172638 0.73 LMNA (0.39) LMNAIGF1RPDE2A
SCHEMBL6174264 0.73 IGF1R (0.43) LMNAMC4RIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed